vs
enCore Energy Corp.(EU)与礼来(RNA)财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是enCore Energy Corp.的1.0倍($12.5M vs $12.4M),enCore Energy Corp.净利率更高(-173.9% vs -1398.3%,领先1224.4%),enCore Energy Corp.自由现金流更多($7.2M vs $-156.9M)
德文能源是一家美国 hydrocarbon 勘探企业,公司注册于特拉华州,运营总部位于俄克拉荷马州俄克拉荷马城的德文能源中心,业务区块主要集中在特拉华盆地、伊格尔福特区块以及落基山脉区域,是美国本土重要的能源勘探开发企业。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,在18个国家设有办事处,产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立,品牌名即取自创始人姓名。
EU vs RNA — 直观对比
营收规模更大
RNA
是对方的1.0倍
$12.4M
净利率更高
EU
高出1224.4%
-1398.3%
自由现金流更多
EU
多$164.0M
$-156.9M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $12.4M | $12.5M |
| 净利润 | $-21.5M | $-174.4M |
| 毛利率 | 37.9% | — |
| 营业利润率 | -135.9% | -1513.5% |
| 净利率 | -173.9% | -1398.3% |
| 营收同比 | — | 434.0% |
| 净利润同比 | — | -117.0% |
| 每股收益(稀释后) | $-0.11 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EU
RNA
| Q4 25 | $12.4M | — | ||
| Q3 25 | $8.9M | $12.5M | ||
| Q2 25 | $3.7M | $3.8M | ||
| Q1 25 | $18.2M | $1.6M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $3.5M |
净利润
EU
RNA
| Q4 25 | $-21.5M | — | ||
| Q3 25 | $-4.8M | $-174.4M | ||
| Q2 25 | $-6.3M | $-157.3M | ||
| Q1 25 | $-24.2M | $-115.8M | ||
| Q4 24 | — | $-102.3M | ||
| Q3 24 | — | $-80.4M | ||
| Q2 24 | — | $-70.8M | ||
| Q1 24 | — | $-68.9M |
毛利率
EU
RNA
| Q4 25 | 37.9% | — | ||
| Q3 25 | 43.8% | — | ||
| Q2 25 | 30.8% | — | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
EU
RNA
| Q4 25 | -135.9% | — | ||
| Q3 25 | -158.2% | -1513.5% | ||
| Q2 25 | -526.1% | -4448.7% | ||
| Q1 25 | -85.7% | -8360.9% | ||
| Q4 24 | — | -4069.6% | ||
| Q3 24 | — | -4200.9% | ||
| Q2 24 | — | -4040.4% | ||
| Q1 24 | — | -2178.6% |
净利率
EU
RNA
| Q4 25 | -173.9% | — | ||
| Q3 25 | -53.7% | -1398.3% | ||
| Q2 25 | -172.7% | -4089.3% | ||
| Q1 25 | -132.9% | -7360.0% | ||
| Q4 24 | — | -3439.5% | ||
| Q3 24 | — | -3441.7% | ||
| Q2 24 | — | -3461.8% | ||
| Q1 24 | — | -1943.4% |
每股收益(稀释后)
EU
RNA
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.03 | $-1.27 | ||
| Q2 25 | $-0.03 | $-1.21 | ||
| Q1 25 | $-0.13 | $-0.90 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.65 | ||
| Q2 24 | — | $-0.65 | ||
| Q1 24 | — | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $52.4M | $350.2M |
| 总债务越低越好 | $110.0M | — |
| 股东权益账面价值 | $229.2M | $1.9B |
| 总资产 | $430.4M | $2.1B |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势,按日历期对齐
现金及短期投资
EU
RNA
| Q4 25 | $52.4M | — | ||
| Q3 25 | $91.9M | $350.2M | ||
| Q2 25 | $26.9M | $243.9M | ||
| Q1 25 | $29.7M | $254.2M | ||
| Q4 24 | — | $219.9M | ||
| Q3 24 | — | $370.2M | ||
| Q2 24 | — | $575.8M | ||
| Q1 24 | — | $471.4M |
总债务
EU
RNA
| Q4 25 | $110.0M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
EU
RNA
| Q4 25 | $229.2M | — | ||
| Q3 25 | $248.6M | $1.9B | ||
| Q2 25 | $264.7M | $1.2B | ||
| Q1 25 | $267.9M | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $830.9M |
总资产
EU
RNA
| Q4 25 | $430.4M | — | ||
| Q3 25 | $441.9M | $2.1B | ||
| Q2 25 | $359.4M | $1.4B | ||
| Q1 25 | $362.6M | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $951.5M |
负债/权益比
EU
RNA
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $12.9M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $7.2M | $-156.9M |
| 自由现金流率自由现金流/营收 | 57.8% | -1257.6% |
| 资本支出强度资本支出/营收 | 46.7% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-45.0M | $-592.3M |
8季度趋势,按日历期对齐
经营现金流
EU
RNA
| Q4 25 | $12.9M | — | ||
| Q3 25 | $-20.3M | $-156.2M | ||
| Q2 25 | $-9.9M | $-199.7M | ||
| Q1 25 | $-7.7M | $-124.8M | ||
| Q4 24 | — | $-99.9M | ||
| Q3 24 | — | $-65.6M | ||
| Q2 24 | — | $-65.0M | ||
| Q1 24 | — | $-70.4M |
自由现金流
EU
RNA
| Q4 25 | $7.2M | — | ||
| Q3 25 | $-26.3M | $-156.9M | ||
| Q2 25 | $-14.1M | $-203.0M | ||
| Q1 25 | $-11.7M | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | — | $-65.5M | ||
| Q1 24 | — | $-71.3M |
自由现金流率
EU
RNA
| Q4 25 | 57.8% | — | ||
| Q3 25 | -296.6% | -1257.6% | ||
| Q2 25 | -385.2% | -5277.1% | ||
| Q1 25 | -64.1% | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | — | -3204.6% | ||
| Q1 24 | — | -2012.3% |
资本支出强度
EU
RNA
| Q4 25 | 46.7% | — | ||
| Q3 25 | 68.0% | 5.7% | ||
| Q2 25 | 115.1% | 86.9% | ||
| Q1 25 | 21.7% | 238.6% | ||
| Q4 24 | — | 131.7% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图